Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator.
Xiong X
,
Bragin A
,
Widdicombe JH
,
Cohn J
,
Skach WR
.
???displayArticle.abstract???
Abnormal folding of mutant cystic fibrosis transmembrane conductance regulator (CFTR) and subsequent degradation in the endoplasmic reticulum is the basis for most cases of cystic fibrosis. Structural differences between wild-type (WT) and mutant proteins, however, remain unknown. Here we examine the intracellular trafficking, degradation, and transmembrane topology of two mutant CFTR proteins, G85E and G91R, each of which contains an additional charged residue within the first putative transmembrane helix (TM1). In microinjected Xenopus laevis oocytes, these mutations markedly disrupted CFTRplasma membrane chloride channel activity. G85E and G91R mutants (but not a conservative mutant, G91A) failed to acquire complex N-linked carbohydrates, and were rapidly degraded before reaching the Golgi complex thus exhibiting a trafficking phenotype similar to DeltaF508 CFTR. Topologic analysis revealed that neither G85E nor G91R mutations disrupted CFTR NH2 terminus transmembrane topology. Instead, WT as well as mutant TM1 spanned the membrane in the predicted C-trans (type II) orientation, and residues 85E and 91R were localized within or adjacent to the plane of the lipid bilayer. To understand how these charged residues might provide structural cues for ER degradation, we examined the stability of WT, G85E, and G91R CFTR proteins truncated at codons 188, 393, 589, or 836 (after TM2, TM6, the first nucleotide binding domain, or the R domain, respectively). These results indicated that G85E and G91R mutations affected CFTR folding, not by gross disruption of transmembrane assembly, but rather through insertion of a charged residue within the plane of the bilayer, which in turn influenced higher order tertiary structure.
Adams,
Incorporation of a charged amino acid into the membrane-spanning domain blocks cell surface transport but not membrane anchoring of a viral glycoprotein.
1985, Pubmed
Adams,
Incorporation of a charged amino acid into the membrane-spanning domain blocks cell surface transport but not membrane anchoring of a viral glycoprotein.
1985,
Pubmed
Akabas,
Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator.
1994,
Pubmed
,
Xenbase
Anderson,
Demonstration that CFTR is a chloride channel by alteration of its anion selectivity.
1991,
Pubmed
BARTH,
Differentiation of cells of the Rana pipiens gastrula in unconditioned medium.
1959,
Pubmed
Bear,
Cl- channel activity in Xenopus oocytes expressing the cystic fibrosis gene.
1991,
Pubmed
,
Xenbase
Bibi,
Organization and stability of a polytopic membrane protein: deletion analysis of the lactose permease of Escherichia coli.
1991,
Pubmed
Bibi,
The N-terminal 22 amino acid residues in the lactose permease of Escherichia coli are not obligatory for membrane insertion or transport activity.
1992,
Pubmed
Blobel,
Intracellular protein topogenesis.
1980,
Pubmed
Bonifacino,
Colocalized transmembrane determinants for ER degradation and subunit assembly explain the intracellular fate of TCR chains.
1990,
Pubmed
Bonifacino,
A peptide sequence confers retention and rapid degradation in the endoplasmic reticulum.
1990,
Pubmed
Brown,
Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
1996,
Pubmed
Calamia,
Membrane protein spanning segments as export signals.
1992,
Pubmed
Carroll,
Alternate translation initiation codons can create functional forms of cystic fibrosis transmembrane conductance regulator.
1995,
Pubmed
,
Xenbase
Chalkley,
A cystic fibrosis patient who is homozygous for the G85E mutation has very mild disease.
1991,
Pubmed
Chang,
Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion.
1994,
Pubmed
Cheng,
Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.
1990,
Pubmed
Cohn,
Characterization of the cystic fibrosis transmembrane conductance regulator in a colonocyte cell line.
1992,
Pubmed
Davis,
A charged amino acid substitution within the transmembrane anchor of the Rous sarcoma virus envelope glycoprotein affects surface expression but not intracellular transport.
1987,
Pubmed
Denning,
Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
1992,
Pubmed
,
Xenbase
Denning,
Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia.
1992,
Pubmed
Drumm,
Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes.
1991,
Pubmed
,
Xenbase
Guillermit,
A novel mutation in exon 3 of the CFTR gene.
1993,
Pubmed
Hartman,
Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product.
1992,
Pubmed
Hartmann,
Predicting the orientation of eukaryotic membrane-spanning proteins.
1989,
Pubmed
Hasegawa,
A multifunctional aqueous channel formed by CFTR.
1992,
Pubmed
,
Xenbase
Higgins,
ABC transporters: from microorganisms to man.
1992,
Pubmed
Hyde,
Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport.
1990,
Pubmed
Jensen,
Multiple proteolytic systems, including the proteasome, contribute to CFTR processing.
1995,
Pubmed
Klausner,
Protein degradation in the endoplasmic reticulum.
1990,
Pubmed
Lippincott-Schwartz,
Degradation from the endoplasmic reticulum: disposing of newly synthesized proteins.
1988,
Pubmed
Lukacs,
Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP.
1994,
Pubmed
Marino,
Localization of the cystic fibrosis transmembrane conductance regulator in pancreas.
1991,
Pubmed
Ohrui,
Radiotracer studies of cystic fibrosis transmembrane conductance regulator expressed in Xenopus oocytes.
1994,
Pubmed
,
Xenbase
Pasyk,
Mutant (delta F508) cystic fibrosis transmembrane conductance regulator Cl- channel is functional when retained in endoplasmic reticulum of mammalian cells.
1995,
Pubmed
Pind,
Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator.
1994,
Pubmed
Reisin,
The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel.
1994,
Pubmed
Riordan,
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
1989,
Pubmed
Rothman,
Construction of defined polytopic integral transmembrane proteins. The role of signal and stop transfer sequence permutations.
1988,
Pubmed
,
Xenbase
Sato,
Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation.
1996,
Pubmed
Sheppard,
The amino-terminal portion of CFTR forms a regulated Cl- channel.
1994,
Pubmed
Skach,
Transmembrane orientation and topogenesis of the third and fourth membrane-spanning regions of human P-glycoprotein (MDR1).
1994,
Pubmed
,
Xenbase
Skach,
Amino-terminal assembly of human P-glycoprotein at the endoplasmic reticulum is directed by cooperative actions of two internal sequences.
1993,
Pubmed
Skach,
Evidence for an alternate model of human P-glycoprotein structure and biogenesis.
1993,
Pubmed
,
Xenbase
Thomas,
The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide.
1992,
Pubmed
Wahle,
Membrane topology of the high-affinity L-glutamate transporter (GLAST-1) of the central nervous system.
1996,
Pubmed
,
Xenbase
Walter,
Preparation of microsomal membranes for cotranslational protein translocation.
1983,
Pubmed
Ward,
Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins.
1994,
Pubmed
Ward,
Degradation of CFTR by the ubiquitin-proteasome pathway.
1995,
Pubmed
Welsh,
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.
1993,
Pubmed
Yang,
The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.
1993,
Pubmed
Zielenski,
Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
1991,
Pubmed
